Cargando…
Association Between the Tissue and Circulating Advanced Glycation End-Products and the Micro- and Macrovascular Complications in Type 1 Diabetes: The DIABAGE Study
INTRODUCTION: Type 1 diabetes is associated with an increased risk of vascular complications. We aimed to investigate the association between serum and tissue advanced glycation end-products (AGEs) and micro- and macrovascular complications in type 1 diabetes (T1D). METHODS: We conducted a cross-sec...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309113/ https://www.ncbi.nlm.nih.gov/pubmed/35779209 http://dx.doi.org/10.1007/s13300-022-01285-1 |
_version_ | 1784753086994055168 |
---|---|
author | Diallo, Alpha M. Jaisson, Stéphane Barriquand, Romain Lukas, Céline Barraud, Sara Decoudier, Bénédicte Francois, Maud Ly, Sang Mahmoudi, Rachid Arndt, Carl Nazeyrollas, Pierre Gillery, Philippe Delemer, Brigitte |
author_facet | Diallo, Alpha M. Jaisson, Stéphane Barriquand, Romain Lukas, Céline Barraud, Sara Decoudier, Bénédicte Francois, Maud Ly, Sang Mahmoudi, Rachid Arndt, Carl Nazeyrollas, Pierre Gillery, Philippe Delemer, Brigitte |
author_sort | Diallo, Alpha M. |
collection | PubMed |
description | INTRODUCTION: Type 1 diabetes is associated with an increased risk of vascular complications. We aimed to investigate the association between serum and tissue advanced glycation end-products (AGEs) and micro- and macrovascular complications in type 1 diabetes (T1D). METHODS: We conducted a cross-sectional study on 196 adults with T1D (mean age 44.53 ± 16, mean duration of diabetes 22 ± 12 years, mean HbA1c 8 ± 1.2%). AGEs were measured in blood serum (i.e., carboxymethyllysine (CML), methylglyoxal-hydroimidazolone-1 (MGH1), and pentosidine) and by measurement of skin autofluorescence (SAF). Associations between AGEs levels and vascular complications were analyzed using binary logistic regression. Correlations between AGEs and pulse wave velocity (PWV) were also assessed by linear regressions. Significant differences were set for p values less than 0.05. RESULTS: We found positive associations between different AGEs and vascular complications. SAF was associated with both microangiopathy (retinopathy: OR = 1.92, p = 0.011; neuropathy: OR = 2.02, p = 0.04; any microangiopathy: OR = 2.83, p < 0.0001) and macroangiopathy (coronaropathy: OR = 3.11, p = 0.009; any macroangiopathy: OR = 2.78, p = 0.003). For circulating AGEs, pentosidine was significantly associated with coronaropathy (OR = 1.61, p = 0.01) and any macroangiopathy (OR = 1.52, p = 0.005) while MGH1 was associated with nephropathy (OR 1.72, p = 0.03). Furthermore, a significant linear correlation was found between PWV and SAF (r = 0.43, p < 0.001), pentosidine (r = 0.28, p < 0.001), and MGH1 (r = 0.16, p = 0.031), but not for CML (r = 0.03, p = 0.598). CONCLUSIONS: Skin autofluorescence appears to be a useful marker for investigating both micro- and macrovascular complications in T1D. In this study, pentosidine was associated with macroangiopathy and MGH1 with nephropathy among the circulating AGEs. Furthermore, the correlations between PWV and AGEs may suggest their value in early prediction of vascular complications in T1D. |
format | Online Article Text |
id | pubmed-9309113 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-93091132022-07-26 Association Between the Tissue and Circulating Advanced Glycation End-Products and the Micro- and Macrovascular Complications in Type 1 Diabetes: The DIABAGE Study Diallo, Alpha M. Jaisson, Stéphane Barriquand, Romain Lukas, Céline Barraud, Sara Decoudier, Bénédicte Francois, Maud Ly, Sang Mahmoudi, Rachid Arndt, Carl Nazeyrollas, Pierre Gillery, Philippe Delemer, Brigitte Diabetes Ther Original Research INTRODUCTION: Type 1 diabetes is associated with an increased risk of vascular complications. We aimed to investigate the association between serum and tissue advanced glycation end-products (AGEs) and micro- and macrovascular complications in type 1 diabetes (T1D). METHODS: We conducted a cross-sectional study on 196 adults with T1D (mean age 44.53 ± 16, mean duration of diabetes 22 ± 12 years, mean HbA1c 8 ± 1.2%). AGEs were measured in blood serum (i.e., carboxymethyllysine (CML), methylglyoxal-hydroimidazolone-1 (MGH1), and pentosidine) and by measurement of skin autofluorescence (SAF). Associations between AGEs levels and vascular complications were analyzed using binary logistic regression. Correlations between AGEs and pulse wave velocity (PWV) were also assessed by linear regressions. Significant differences were set for p values less than 0.05. RESULTS: We found positive associations between different AGEs and vascular complications. SAF was associated with both microangiopathy (retinopathy: OR = 1.92, p = 0.011; neuropathy: OR = 2.02, p = 0.04; any microangiopathy: OR = 2.83, p < 0.0001) and macroangiopathy (coronaropathy: OR = 3.11, p = 0.009; any macroangiopathy: OR = 2.78, p = 0.003). For circulating AGEs, pentosidine was significantly associated with coronaropathy (OR = 1.61, p = 0.01) and any macroangiopathy (OR = 1.52, p = 0.005) while MGH1 was associated with nephropathy (OR 1.72, p = 0.03). Furthermore, a significant linear correlation was found between PWV and SAF (r = 0.43, p < 0.001), pentosidine (r = 0.28, p < 0.001), and MGH1 (r = 0.16, p = 0.031), but not for CML (r = 0.03, p = 0.598). CONCLUSIONS: Skin autofluorescence appears to be a useful marker for investigating both micro- and macrovascular complications in T1D. In this study, pentosidine was associated with macroangiopathy and MGH1 with nephropathy among the circulating AGEs. Furthermore, the correlations between PWV and AGEs may suggest their value in early prediction of vascular complications in T1D. Springer Healthcare 2022-07-02 2022-08 /pmc/articles/PMC9309113/ /pubmed/35779209 http://dx.doi.org/10.1007/s13300-022-01285-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Original Research Diallo, Alpha M. Jaisson, Stéphane Barriquand, Romain Lukas, Céline Barraud, Sara Decoudier, Bénédicte Francois, Maud Ly, Sang Mahmoudi, Rachid Arndt, Carl Nazeyrollas, Pierre Gillery, Philippe Delemer, Brigitte Association Between the Tissue and Circulating Advanced Glycation End-Products and the Micro- and Macrovascular Complications in Type 1 Diabetes: The DIABAGE Study |
title | Association Between the Tissue and Circulating Advanced Glycation End-Products and the Micro- and Macrovascular Complications in Type 1 Diabetes: The DIABAGE Study |
title_full | Association Between the Tissue and Circulating Advanced Glycation End-Products and the Micro- and Macrovascular Complications in Type 1 Diabetes: The DIABAGE Study |
title_fullStr | Association Between the Tissue and Circulating Advanced Glycation End-Products and the Micro- and Macrovascular Complications in Type 1 Diabetes: The DIABAGE Study |
title_full_unstemmed | Association Between the Tissue and Circulating Advanced Glycation End-Products and the Micro- and Macrovascular Complications in Type 1 Diabetes: The DIABAGE Study |
title_short | Association Between the Tissue and Circulating Advanced Glycation End-Products and the Micro- and Macrovascular Complications in Type 1 Diabetes: The DIABAGE Study |
title_sort | association between the tissue and circulating advanced glycation end-products and the micro- and macrovascular complications in type 1 diabetes: the diabage study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309113/ https://www.ncbi.nlm.nih.gov/pubmed/35779209 http://dx.doi.org/10.1007/s13300-022-01285-1 |
work_keys_str_mv | AT dialloalpham associationbetweenthetissueandcirculatingadvancedglycationendproductsandthemicroandmacrovascularcomplicationsintype1diabetesthediabagestudy AT jaissonstephane associationbetweenthetissueandcirculatingadvancedglycationendproductsandthemicroandmacrovascularcomplicationsintype1diabetesthediabagestudy AT barriquandromain associationbetweenthetissueandcirculatingadvancedglycationendproductsandthemicroandmacrovascularcomplicationsintype1diabetesthediabagestudy AT lukasceline associationbetweenthetissueandcirculatingadvancedglycationendproductsandthemicroandmacrovascularcomplicationsintype1diabetesthediabagestudy AT barraudsara associationbetweenthetissueandcirculatingadvancedglycationendproductsandthemicroandmacrovascularcomplicationsintype1diabetesthediabagestudy AT decoudierbenedicte associationbetweenthetissueandcirculatingadvancedglycationendproductsandthemicroandmacrovascularcomplicationsintype1diabetesthediabagestudy AT francoismaud associationbetweenthetissueandcirculatingadvancedglycationendproductsandthemicroandmacrovascularcomplicationsintype1diabetesthediabagestudy AT lysang associationbetweenthetissueandcirculatingadvancedglycationendproductsandthemicroandmacrovascularcomplicationsintype1diabetesthediabagestudy AT mahmoudirachid associationbetweenthetissueandcirculatingadvancedglycationendproductsandthemicroandmacrovascularcomplicationsintype1diabetesthediabagestudy AT arndtcarl associationbetweenthetissueandcirculatingadvancedglycationendproductsandthemicroandmacrovascularcomplicationsintype1diabetesthediabagestudy AT nazeyrollaspierre associationbetweenthetissueandcirculatingadvancedglycationendproductsandthemicroandmacrovascularcomplicationsintype1diabetesthediabagestudy AT gilleryphilippe associationbetweenthetissueandcirculatingadvancedglycationendproductsandthemicroandmacrovascularcomplicationsintype1diabetesthediabagestudy AT delemerbrigitte associationbetweenthetissueandcirculatingadvancedglycationendproductsandthemicroandmacrovascularcomplicationsintype1diabetesthediabagestudy |